These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9061507)

  • 1. Galanin positively modulates prolactin secretion in normal women.
    Grottoli S; Arvat E; Gianotti L; Ramunni J; Di Vito L; Maccagno B; Ciccarelli E; Camanni F; Ghigo E
    J Endocrinol Invest; 1996 Dec; 19(11):739-44. PubMed ID: 9061507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.
    Invitti C; Pecori Giraldi F; Tagliaferri A; Scacchi M; Dubini A; Cavagnini F
    Clin Endocrinol (Oxf); 1993 Aug; 39(2):213-6. PubMed ID: 7690312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of galanin and serotonin on the endocrine response to Hexarelin, a synthetic peptidyl GH-secretagogue, in normal women.
    Arvat E; Maccagno B; Ramunni J; Broglio F; Lanfranco F; Giordano R; Benso A; Deghenghi R; Ghigo E
    J Endocrinol Invest; 1998 Nov; 21(10):673-9. PubMed ID: 9854683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man.
    Ghigo E; Maccario M; Arvat E; Valetto MR; Valente F; Nicolosi M; Mazza E; Martina V; Cocchi D; Camanni F
    Metabolism; 1992 Jan; 41(1):85-9. PubMed ID: 1371576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans.
    Arvat E; Gianotti L; Ramunni J; Grottoli S; Brossa PC; Bertagna A; Camanni F; Ghigo E
    Eur J Endocrinol; 1995 Sep; 133(3):300-4. PubMed ID: 7581945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J; Müller OA; Schopohl J; von Werder K
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man.
    Ho KY; Smythe GA; Lazarus L
    Clin Endocrinol (Oxf); 1985 Jul; 23(1):7-16. PubMed ID: 3928213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential effects of galanin-(1-30) and -(3-30) on anterior pituitary hormone secretion in vivo in humans.
    Todd JF; Edwards CM; Ghatei MA; Bloom SR
    Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1060-6. PubMed ID: 10827009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
    Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
    J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin does not modify the prolactin response to metoclopramide in normal women.
    Chiodera P; Volpi R; Gramellini D; Cigarini C; Corradi A; Cavazzini U; Bianconi L; Papadia C; Caiazza A; Capretti L
    J Endocrinol Invest; 1991 Jun; 14(6):463-8. PubMed ID: 1774442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of metoclopramide on the growth hormone response to galanin in normal man.
    Giustina A; Bussi AR; Doga M; Licini M; Schettino M; Wehrenberg WB
    Horm Metab Res; 1993 Sep; 25(9):489-92. PubMed ID: 7693566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia.
    Nicoletti I; Ambrosi F; Pagliacci MC; Pelicci G; Giammartino C; Maggio D; Fedeli L; Filipponi P
    Horm Metab Res; 1987 Mar; 19(3):125-9. PubMed ID: 3106177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histaminergic regulation of prolactin secretion: dose-response relationship and possible involvement of the dopaminergic system.
    Knigge U; Thuesen B; Christiansen PM
    J Clin Endocrinol Metab; 1986 Mar; 62(3):491-6. PubMed ID: 3944233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin and growth hormone secretion after thyrotrophin-releasing hormone infusion and dopaminergic (DA2) blockade in infertile patients with minimal/mild endometriosis.
    Cunha-Filho JS; Gross JL; Lemos NA; Dias EC; Vettori D; Souza CA; Passos EP
    Hum Reprod; 2002 Apr; 17(4):960-5. PubMed ID: 11925390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
    Michalkiewicz M; Suzuki M; Kato M
    Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyrotropin-releasing hormone and metoclopramide on PRL secretion in normally cycling and amenorrheic alcoholic women.
    Vescovi PP; Coiro V
    Drug Alcohol Depend; 1997 Apr; 45(1-2):115-9. PubMed ID: 9179513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa.
    De Marinis L; Mancini A; Valle D; Bianchi A; Gentilella R; Milardi D; Mascadri C; Giustina A
    Metabolism; 2000 Feb; 49(2):155-9. PubMed ID: 10690937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galanin is a physiological regulator of spontaneous pulsatile secretion of growth hormone in the male rat.
    Maiter DM; Hooi SC; Koenig JI; Martin JB
    Endocrinology; 1990 Feb; 126(2):1216-22. PubMed ID: 1688791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are fasting-induced effects on thyrotropin and prolactin secretion mediated by dopamine?
    Röjdmark S
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1266-70. PubMed ID: 6404923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the central and peripheral dopaminergic control of PRL secretion in man: failure to demonstrate the existence of a dopamine-mediated prolactin-inhibiting factor.
    Ho KY; Smythe GA; Lazarus L
    Neuroendocrinology; 1985 Jun; 40(6):457-62. PubMed ID: 3925361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.